As of April 2024 Arcadia Biosciences has a market cap of $2.8 Million. This makes Arcadia Biosciences the world's 8281th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.8 M | -19.22% |
2023 | $3.47 M | -47.96% |
2022 | $6.67 M | -71.05% |
2021 | $23.07 M | -32.2% |
2020 | $34.03 M | -28.18% |
2019 | $47.38 M | 213.02% |
2018 | $15.13 M | 28.95% |
2017 | $11.73 M | -71.32% |
2016 | $40.92 M | -69.53% |
2015 | $0.13 B |
On Apr 19th, 2024 the market cap of Arcadia Biosciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Marrone Bio Innovations
MBII | $0.14 B | 5,084.63% | ๐บ๐ธ USA |
Codexis
CDXS | $0.19 B | 6,986.83% | ๐บ๐ธ USA |
ScottsMiracle-Gro SMG | $3.78 B | 134,671.55% | ๐บ๐ธ USA |
American Vanguard AVD | $0.31 B | 11,295.16% | ๐บ๐ธ USA |